Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
OCTREOTIDE-MODIFIED NANO PREPARATION FOR TREATMENT OF CANCER OR PALLIATIVE CARE OF CANCER
Document Type and Number:
WIPO Patent Application WO/2012/035794
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for the treatment, palliative care or prevention of cancer such as medullary thyroid carcinoma. Specifically, the present invention relates to a pharmaceutical composition for the treatment, palliative care or prevention of cancer such as medullary thyroid carcinoma, which contains a liposome modified with octreotide.

Inventors:
IWASE YUKO
MAITANI YOSHIE
Application Number:
PCT/JP2011/053890
Publication Date:
March 22, 2012
Filing Date:
February 23, 2011
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANOSION CO LTD (JP)
IWASE YUKO
MAITANI YOSHIE
International Classes:
A61K9/127; A61K38/08; A61K31/4745; A61K47/34; A61K47/42; A61P35/00
Foreign References:
JP2002047298A2002-02-12
Other References:
"Octreotide Shushoku Liposome Seizai no Chosei to in vitro Hyoka, 28CE-pm03", ABSTRACTS OF 130TH ANNUAL MEETING OF PHARMACEUTICAL SOCIETY OF JAPAN, 5 March 2010 (2010-03-05)
FOOD AND CHEMICAL TOXICOLOGY, vol. 46, no. 9, 2008, pages 3116 - 3121
BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 72, no. 6, 2008, pages 1586 - 1594
JOURNAL OF CLINICAL ONCOLOGY, vol. 8, no. 11, 1990, pages 1907 - 1912
Attorney, Agent or Firm:
TSUKUNI, HAJIME (JP)
Hajime Tsukuni (JP)
Download PDF:
Claims: